[The antiviral properties of Corynebacterium parvum].
D000818:Animals; D001202:Ascitic Fluid / Q000166:cytology / Q000276:immunology; D002478:Cells, Cultured; D003352:Corynebacterium / Q000276:immunology*; D003609:Dactinomycin / Q000494:pharmacology; D004686:Encephalomyocarditis virus / Q000276:immunology*; D007369:Interferon Inducers / Q000096:biosynthesis; D007372:Interferons / Q000096:biosynthesis / Q000494:pharmacology; D008264:Macrophages / Q000276:immunology; D051379:Mice / Q000276:immunology; D008810:Mice, Inbred C57BL / Q000276:immunology; D011425:Propionibacterium acnes / Q000276:immunology*; D013045:Species Specificity; D013696:Temperature; D013997:Time Factors; D014721:Vesicular stomatitis Indiana virus / Q000276:immunology*; D014779:Virus Replication / Q000187:drug effects
D007369:Interferon Inducers; D003609:Dactinomycin; D007372:Interferons
Propriétés antivirales du C. parvum